Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


New Step Towards Eradication of H5N1 Bird Flu


A University of Adelaide-led project has developed a new test that can distinguish between birds that have been vaccinated against the H5N1 strain of avian influenza virus or “bird flu” with those that have been naturally infected.

This is a significant step in the fight against this often fatal strain of avian influenza which is widespread in the poultry populations of South East Asia, particularly Indonesia and Vietnam.

It causes global concern because of its possible transmission to humans and the threat of a pandemic if it mutates to a form that can be easily passed from bird to human then human to human. The research has been published in PLOS ONE.

“Avian flu is on the top list of notifiable diseases of the World Organization for Animal Health (OIE) because of its high economic cost and risk to human health,” says project leader Dr Farhid Hemmatzadeh, Senior Lecturer in Virology in the School of Animal and Veterinary Sciences at the Roseworthy campus.

“Outbreaks in birds are largely being controlled by vaccination and this is limiting human exposure to this virus.

“But the inability of distinguishing between vaccinated and naturally infected birds has been a major challenge. It has prevented tracking the virus which can still circulate in vaccinated birds and may mutate to new strains under what’s called vaccination pressure.

“These birds that have been vaccinated but still have live naturally infected H5N1 virus in their systems are the main source of emerging strains of the virus - and these new strains may be even more dangerous to birds or humans.

“With this new, more sensitive, test we can identify these vaccinated birds with live virus and prevent the escape of any mutant strains. This is essential if we want to prevent pandemics developing from this virus and eventually eradicate this disease.”

The researchers, including the University of Melbourne, CSIRO and Indonesian organisations, are carrying out large surveillance programs in poultry farms across Indonesia. The research is funded by the Australian Centre for International Agricultural Research (ACIAR).

The bird vaccine is made from avian influenza virus which has been killed but still promotes the production of antibodies in the bird protecting it against the live virus. The antibodies prevent the replication of the virus in the bird, but in some cases the virus mutates in a vaccinated bird and can still replicate even with the existing high level of antibodies to the vaccines.

The new DIVA test (differentiation of infected from vaccinated animals) uses a particular viral protein called Matrix protein 2 that reacts differently with blood serum from vaccinated or infected animals. Since the first outbreak of H5N1 avian influenza virus in 2004, the development of a reliable DIVA test has been global priority.

Media Contact:

Dr Farhid Hemmatzadeh
Senior Lecturer, School of Animal and Veterinary Sciences
The University of Adelaide
Phone: +61 8 8313 7723
Mobile: +61 (0)410 749 766

Robyn Mills
Media and Communications Officer
The University of Adelaide
Phone: +61 8 8313 6341
Mobile: +61 410 689 084

Robyn Mills | newswise
Further information:

More articles from Health and Medicine:

nachricht Scientists develop tiny tooth-mounted sensors that can track what you eat
22.03.2018 | Tufts University

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Custom sequences for polymers using visible light

22.03.2018 | Materials Sciences

Scientists develop tiny tooth-mounted sensors that can track what you eat

22.03.2018 | Health and Medicine

Mat baits, hooks and destroys pollutants in water

22.03.2018 | Earth Sciences

Science & Research
Overview of more VideoLinks >>>